Insiders · DFTX

DFTX insider transactions

Definium Therapeutics Inc. (DFTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for DFTX

• 73d
  SEC Form 4 filed by Karlin Daniel

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 73d
  SEC Form 4 filed by Sullivan Mark

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 73d
  SEC Form 4 filed by Barrow Robert

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 122d
  Chief Commercial Officer Wiley Matthew T. was granted 115,000 shares (SEC Form 4)

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 122d
  Chief Financial Officer Roberts Brandi was granted 150,000 shares (SEC Form 4)

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 122d
  Chief Legal Officer Sullivan Mark was granted 125,000 shares, increasing direct ownership by 44% to 407,576 units (SEC Form 4)

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 122d
  Chief Medical Officer Karlin Daniel was granted 150,000 shares, increasing direct ownership by 35% to 575,025 units (SEC Form 4)

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 122d
  Chief Executive Officer Barrow Robert was granted 320,000 shares, increasing direct ownership by 41% to 1,098,477 units (SEC Form 4)

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 129d
  SEC Form 4 filed by Director Adsett Roger

  4 - Definium Therapeutics, Inc. (0001813814) (Issuer)
• 129d
  SEC Form 3 filed by new insider Adsett Roger

  3 - Definium Therapeutics, Inc. (0001813814) (Issuer)